2 Invincible Dividend Shares To Buy If There’s A Promotion-Off In The Accumulation Market

Dividend stocks trade surprisingly well to help you add money to your portfolio and compound your total returns as you age. Whether you value dividend money to add to your portfolio or to cash it out, all of these stocks can help you diversify the types of companies in which you hold stock.

When it comes to investing in dividend stocks, you need to make sure that the companies you buy have a strong underlying industry and stability sheet that can support and help grow the dividends they are paying. Having a lead dividend will also have a historical past of maintaining and growing its dividend across a wide range of market environments.

On that observation, listed below are two prime dividend stocks to trust in your portfolio. Everyone plays smart, whether the market continues to be bullish or investor sentiment remains bearish. If the market pulls back, those stocks have proven to be long-term holdings.

1. Johnson & Johnson

johnson and johnson (NYSE: JNJ) It has paid and increased its dividend every 12 months for the last 62 years. This adds the pharmaceutical sector to the group of companies that have earned the Dividend King nickname.

J&J has a post dividend advance of 3.4%, which is more than twice the average post S&P 500 share. Looking at the last decade, Johnson & Johnson’s dividend has grown an average of 6% per year. Its payout ratio is a highly manageable 30%.

J&J’s dividend is helping to make up for Keep’s significantly weaker maintenance efficiency over the past several years. The weak performance also helps explain the slightly above-average post. The store is in bad shape for a number of reasons, though the biggest one is the ongoing litigation and potential billions of dollars of liabilities associated with its talc products. The company has $26 billion of cash on its stability sheet to help lead the ongoing court cases and ultimately make additional payments to shareholders to maintain its stability.

Investing in Johnson & Johnson means putting money into a company that has been in the industry for 138 years, and is one of the world’s leading pharmaceutical companies in terms of earnings. Over the past 365 days, the company has made more than $17 billion on revenues of approximately $86 billion. Additionally, approximately $24 billion has been generated from leveraged independent money tides in the last 365 days.

Over the past 12 months, J&J transformed its slow-growing consumer health care products arm into an organization Kenview, The remaining two categories – prescription drugs and clinical gadgets – are growing rapidly and should help J&J boost its growth efforts in the coming years. The company has returned approximately 60% of free cash flow to investors over the last five years, while 65% of gross sales come from products for which it controls the leading or second global market share position.

the story continues

Bottom line, this probably isn’t an industry for growth-oriented investors. On the other hand, long-term investors looking for an organization that generates secure financial returns from a broad portfolio of reliable prescription drugs and clinical gadgets could potentially find Johnson & Johnson to be an attractive investment option. Combined with its low performance value, Johnson & Johnson’s historic dividend makes the industry an attractive choice for income-seeking investors. When its underlying problems, including costly litigation, are eventually resolved, the disproportionate cost is more likely to be at one’s feet.

2. Coca-Cola

Coca-Cola (NYSE:KO) Boasts a dividend yield of around 3% and has been faithfully increasing its dividend every year for the last 62 years. Beverage Immense doesn’t generate extremely stable price gains in this day and age, but its dividend and percentage value growth have helped it generate a total return of 46% over the last five years and a return of over 108% over the last 10 years. Year period.

Established in 1886, the corporate now manages some of the largest beverage operations on earth. Coca-Cola controls approximately 46% of the soft drink market in the US, considered one of its largest markets.

Over the past 365 days, Coca-Cola has lost nearly $11 billion on revenues of $46 billion. It has maintained a profit margin of around 23%, which is an unprecedented figure in a business where margins are traditionally very low. The company’s payout ratio is around 74%, which is quite good but still moderately manageable. Its dividend has grown an average of 5% each year over the past decade.

In just 365 days, the company has brought in cash tide of approximately $12 billion, which includes free cash tide of nearly $11 billion. Foreign exchange headwinds and fluctuating macro conditions have hampered the company’s progress over the years, although the sustainability of its dividend and the strength of its stability sheet remain testament to the industry’s resilience.

Long-term buy-and-hold investors looking for safe portfolio growth and dividends may find a batch to like about Coca-Cola.

Should you invest $1,000 in Johnson & Johnson right now?

Before you shop at Johnson & Johnson, believe this:

Motley Fool Marketing Consultant The analyst workforce simply identified what they envision 10 highest shares For traders to buy right now… and Johnson & Johnson wasn’t supposed to be one of them. The ten stocks that made the cut could deliver tremendous returns in the coming years.

believe when NVIDIA This list was created on April 15, 2005… For those who invested $1,000 as per our advice, depending on the age, You will have $757,001,

accumulation marketing consultant Offers investors an easy-to-follow blueprint for good fortune, including guidance on building a portfolio, regular updates from analysts and two ancient options each. accumulation marketing consultant the carrier has more than quadruple S&P 500 returns since 2002*.

View ten shares »

*Withdrawal of Sanchay Marketing Consultant is till June 24, 2024

Rachel Warren holds positions at Johnson & Johnson. The Motley Idiot has the post and recommends Kenview. The Motley Idiot recommends Johnson & Johnson and suggests please check out the alternative: Long January 2026 screams $13 at Kenview. The Motley Idiot has disclosure coverage.

2 Unstoppable Dividend Stocks to Buy If There’s an Accumulation Market, initially printed by The Motley Idiot.